Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05201014 · ClinicalTrials.gov registry record
Cancer Survivor Cardiomyopathy Detection
A clinical trial of Cancer and Cardiovascular Diseases, sponsored by Mayo Clinic.
- Active
- Registry status
- 112
- Enrollment target
- 1
- Study location
NCT05201014: Active study of Cancer and Cardiovascular Diseases, sponsored by Mayo Clinic.
NCT05201014 is a study of Cancer and Cardiovascular Diseases that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 112 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05201014, a study of Cancer and Cardiovascular Diseases, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- 112 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to improve the cardiovascular care of adult cancer survivors. The goal is to obtain the data necessary to plan and develop a nation-wide network of a screening program that can help provide cost-effective and long-term monitoring.
Primary Outcome
Determination of the sensitivity, specificity, positive and negative prediction value as well as area under the curve for receiver operating characteristics for the 12-lead AI ECG algorithm for an LVEF \<50%
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Echocardiogram
- DIAGNOSTIC_TEST Electrocardiogram
- DIAGNOSTIC_TEST NT-pro-BNP
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2022-03-03 |
| Est. Completion | 2026-09-20 |
What the registry record for NCT05201014 still lists
NCT05201014 is an observational study that tracks outcomes without assigning an intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 3 interventions - of which Echocardiogram is the first listed.
NCT05201014 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05201014 about?
NCT05201014 is a clinical study titled "Cancer Survivor Cardiomyopathy Detection". The purpose of this study is to improve the cardiovascular care of adult cancer survivors. The goal is to obtain the data necessary to plan and develop a nation-wide network of a screening program that can help provide cost-effective and long-term monitoring.
What is the current status of trial NCT05201014?
This trial is currently active not recruiting. The enrollment target is 112 participants. The study started on 2022-03-03. Estimated completion is 2026-09-20.
What conditions does trial NCT05201014 study?
This clinical trial studies the following conditions: Cancer, Cardiovascular Diseases.
What interventions are being tested in trial NCT05201014?
The interventions under investigation include: Echocardiogram (DIAGNOSTIC_TEST), Electrocardiogram (DIAGNOSTIC_TEST), NT-pro-BNP (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05201014?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05201014 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05201014's enrollment target sits among peer trials
112 300th of 615 higher than 314 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04511013 · 112 participants · Phase 2
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- NCT04551560 · 112 participants · NA
Stress and Congestive Heart Failure
- NCT04872166 · 112 participants · Phase 1
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
- NCT05024773 · 112 participants · Phase 3
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI